# Raltegravir and Ezetimibe PK Study

> **NCT00772551** · PHASE1 · COMPLETED · sponsor: **St Stephens Aids Trust** · enrollment: 26 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Raltegravir and ezetimibe
- **DRUG:** Ezetimibe and raltegravir

## Key facts

- **NCT ID:** NCT00772551
- **Lead sponsor:** St Stephens Aids Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2010-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00772551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00772551, "Raltegravir and Ezetimibe PK Study". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00772551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*